Global Dasatinib Drugs Market Growth 2022-2028
- LP 4850270
- 78 Pages
- February 2022
- Pharmaceuticals
The United States Dasatinib Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dasatinib Drugs market, reaching US$ million by the year 2028. As for the Europe Dasatinib Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dasatinib Drugs players cover Bristol-Myers Squibb, LUCIUS Pharma, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dasatinib Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
20mg
50mg
70mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
CML
ALL
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bristol-Myers Squibb
LUCIUS Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dasatinib Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dasatinib Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dasatinib Drugs by Country/Region, 2017, 2022 & 2028
2.2 Dasatinib Drugs Segment by Type
2.2.1 20mg
2.2.2 50mg
2.2.3 70mg
2.3 Dasatinib Drugs Sales by Type
2.3.1 Global Dasatinib Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Dasatinib Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dasatinib Drugs Sale Price by Type (2017-2022)
2.4 Dasatinib Drugs Segment by Application
2.4.1 CML
2.4.2 ALL
2.5 Dasatinib Drugs Sales by Application
2.5.1 Global Dasatinib Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Dasatinib Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dasatinib Drugs Sale Price by Application (2017-2022)
3 Global Dasatinib Drugs by Company
3.1 Global Dasatinib Drugs Breakdown Data by Company
3.1.1 Global Dasatinib Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Dasatinib Drugs Sales Market Share by Company (2020-2022)
3.2 Global Dasatinib Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Dasatinib Drugs Revenue by Company (2020-2022)
3.2.2 Global Dasatinib Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Dasatinib Drugs Sale Price by Company
3.4 Key Manufacturers Dasatinib Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dasatinib Drugs Product Location Distribution
3.4.2 Players Dasatinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dasatinib Drugs by Geographic Region
4.1 World Historic Dasatinib Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Dasatinib Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dasatinib Drugs Annual Revenue by Geographic Region
4.2 World Historic Dasatinib Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Dasatinib Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dasatinib Drugs Annual Revenue by Country/Region
4.3 Americas Dasatinib Drugs Sales Growth
4.4 APAC Dasatinib Drugs Sales Growth
4.5 Europe Dasatinib Drugs Sales Growth
4.6 Middle East & Africa Dasatinib Drugs Sales Growth
5 Americas
5.1 Americas Dasatinib Drugs Sales by Country
5.1.1 Americas Dasatinib Drugs Sales by Country (2017-2022)
5.1.2 Americas Dasatinib Drugs Revenue by Country (2017-2022)
5.2 Americas Dasatinib Drugs Sales by Type
5.3 Americas Dasatinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dasatinib Drugs Sales by Region
6.1.1 APAC Dasatinib Drugs Sales by Region (2017-2022)
6.1.2 APAC Dasatinib Drugs Revenue by Region (2017-2022)
6.2 APAC Dasatinib Drugs Sales by Type
6.3 APAC Dasatinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dasatinib Drugs by Country
7.1.1 Europe Dasatinib Drugs Sales by Country (2017-2022)
7.1.2 Europe Dasatinib Drugs Revenue by Country (2017-2022)
7.2 Europe Dasatinib Drugs Sales by Type
7.3 Europe Dasatinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dasatinib Drugs by Country
8.1.1 Middle East & Africa Dasatinib Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dasatinib Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Dasatinib Drugs Sales by Type
8.3 Middle East & Africa Dasatinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dasatinib Drugs
10.3 Manufacturing Process Analysis of Dasatinib Drugs
10.4 Industry Chain Structure of Dasatinib Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dasatinib Drugs Distributors
11.3 Dasatinib Drugs Customer
12 World Forecast Review for Dasatinib Drugs by Geographic Region
12.1 Global Dasatinib Drugs Market Size Forecast by Region
12.1.1 Global Dasatinib Drugs Forecast by Region (2023-2028)
12.1.2 Global Dasatinib Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dasatinib Drugs Forecast by Type
12.7 Global Dasatinib Drugs Forecast by Application
13 Key Players Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Dasatinib Drugs Product Offered
13.1.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
14 Research Findings and Conclusion
Table 1. Dasatinib Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dasatinib Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 20mg
Table 4. Major Players of 50mg
Table 5. Major Players of 70mg
Table 6. Global Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Dasatinib Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Dasatinib Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Dasatinib Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Dasatinib Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Dasatinib Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Dasatinib Drugs Revenue by Application (2017-2022)
Table 14. Global Dasatinib Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Dasatinib Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Dasatinib Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Dasatinib Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Dasatinib Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Dasatinib Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Dasatinib Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Dasatinib Drugs Producing Area Distribution and Sales Area
Table 22. Players Dasatinib Drugs Products Offered
Table 23. Dasatinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Dasatinib Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Dasatinib Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Dasatinib Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Dasatinib Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Dasatinib Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Dasatinib Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Dasatinib Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Dasatinib Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Dasatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Dasatinib Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Dasatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Dasatinib Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Dasatinib Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Dasatinib Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Dasatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Dasatinib Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Dasatinib Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Dasatinib Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Dasatinib Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Dasatinib Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Dasatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Dasatinib Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Dasatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Dasatinib Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Dasatinib Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Dasatinib Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Dasatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Dasatinib Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Dasatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Dasatinib Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Dasatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Dasatinib Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Dasatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Dasatinib Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Dasatinib Drugs
Table 67. Key Market Challenges & Risks of Dasatinib Drugs
Table 68. Key Industry Trends of Dasatinib Drugs
Table 69. Dasatinib Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Dasatinib Drugs Distributors List
Table 72. Dasatinib Drugs Customer List
Table 73. Global Dasatinib Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Dasatinib Drugs Sales Market Forecast by Region
Table 75. Global Dasatinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Dasatinib Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Dasatinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Dasatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Dasatinib Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Dasatinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Dasatinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Dasatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Dasatinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Dasatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Dasatinib Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Dasatinib Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Dasatinib Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Dasatinib Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Dasatinib Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Dasatinib Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Dasatinib Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Dasatinib Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Bristol-Myers Squibb Basic Information, Dasatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Bristol-Myers Squibb Dasatinib Drugs Product Offered
Table 95. Bristol-Myers Squibb Dasatinib Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Bristol-Myers Squibb Main Business
Table 97. Bristol-Myers Squibb Latest Developments
Table 98. LUCIUS Pharma Basic Information, Dasatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. LUCIUS Pharma Dasatinib Drugs Product Offered
Table 100. LUCIUS Pharma Dasatinib Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. LUCIUS Pharma Main Business
Table 102. LUCIUS Pharma Latest Developments
List of Figures
Figure 1. Picture of Dasatinib Drugs
Figure 2. Dasatinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dasatinib Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Dasatinib Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dasatinib Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 20mg
Figure 10. Product Picture of 50mg
Figure 11. Product Picture of 70mg
Figure 12. Global Dasatinib Drugs Sales Market Share by Type in 2021
Figure 13. Global Dasatinib Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Dasatinib Drugs Consumed in CML
Figure 15. Global Dasatinib Drugs Market: CML (2017-2022) & (K Units)
Figure 16. Dasatinib Drugs Consumed in ALL
Figure 17. Global Dasatinib Drugs Market: ALL (2017-2022) & (K Units)
Figure 18. Global Dasatinib Drugs Sales Market Share by Application (2017-2022)
Figure 19. Global Dasatinib Drugs Revenue Market Share by Application in 2021
Figure 20. Dasatinib Drugs Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Dasatinib Drugs Revenue Market Share by Company in 2021
Figure 22. Global Dasatinib Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Dasatinib Drugs Revenue Market Share by Geographic Region in 2021
Figure 24. Global Dasatinib Drugs Sales Market Share by Region (2017-2022)
Figure 25. Global Dasatinib Drugs Revenue Market Share by Country/Region in 2021
Figure 26. Americas Dasatinib Drugs Sales 2017-2022 (K Units)
Figure 27. Americas Dasatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 28. APAC Dasatinib Drugs Sales 2017-2022 (K Units)
Figure 29. APAC Dasatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 30. Europe Dasatinib Drugs Sales 2017-2022 (K Units)
Figure 31. Europe Dasatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Dasatinib Drugs Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Dasatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Americas Dasatinib Drugs Sales Market Share by Country in 2021
Figure 35. Americas Dasatinib Drugs Revenue Market Share by Country in 2021
Figure 36. United States Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Dasatinib Drugs Sales Market Share by Region in 2021
Figure 41. APAC Dasatinib Drugs Revenue Market Share by Regions in 2021
Figure 42. China Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Dasatinib Drugs Sales Market Share by Country in 2021
Figure 49. Europe Dasatinib Drugs Revenue Market Share by Country in 2021
Figure 50. Germany Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Dasatinib Drugs Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Dasatinib Drugs Revenue Market Share by Country in 2021
Figure 57. Egypt Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Dasatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Dasatinib Drugs in 2021
Figure 63. Manufacturing Process Analysis of Dasatinib Drugs
Figure 64. Industry Chain Structure of Dasatinib Drugs
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
